Download PDF

Other users also viewed these articles

Economic evaluation of long-term albumin use in cirrhosis patients from the Mexican healthcare system perspective Carlos Moctezuma-Velazquez; Graciela Castro-Narro; Pablo Simó; Elisabet Viayna; Susana Aceituno; Maria Soler; Aldo Torre;
10.1016/j.aohep.2022.100673
Long-term albumin treatment for decompensated cirrhosis in Italy: A propensity score-matched, retrospective, real-world chart analysis Wim Laleman; Jonel Trebicka; Alastair O¿Brien; Giacomo Zaccherini; Paolo Caraceni; Joana F. Rodrigues; Xiang Zhang; Maebh Kelly; Kyle Rodney; Sofia Schweiger; Paolo Angeli;
Ann Hepatol. 2026;31:
Position statement on the use of albumin in liver cirrhosis Graciela Castro-Narro; Carlos Moctezuma-Velázquez; Rene Male-Velázquez; Rafael Trejo-Estrada; Francisco Javier Bosques; Rosalba Moreno-Alcántar; Heriberto Rodríguez-Hernández; Aleida Bautista-Santos; Carlos Córtez-Hernández; Eira Cerda-Reyes; Juanita Pérez-Escobar; Juan Manuel Aldana-Ledesma; Jonathan Aguirre-Valadez; José Antonio Velarde Ruiz-Velasco; Raúl Contreras-Omaña; Godolfino Miranda-Zazueta; Monica del Rocío Reyes-Bastidas; Javier Manuel Meza-Cardona; Norberto Chávez-Tapia; Nicolas Joaquín Fernández-Pérez; Edgar Santino García-Jiménez; Aldo Torre;
10.1016/j.aohep.2022.100708